SG Americas Securities’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $938K | Buy |
39,826
+4,597
| +13% | +$117K | ﹤0.01% | 1793 |
|
|
2025
Q4 | $1.02M | Buy |
35,229
+17,814
| +102% | +$456K | ﹤0.01% | 1998 |
|
|
2025
Q3 | $328K | Buy |
+17,415
| New | +$275K | ﹤0.01% | 2416 |
|
|
2025
Q2 | – | Sell |
-32,566
| Closed | -$509K | – | 2925 |
|
|
2025
Q1 | $509K | Sell |
32,566
-15,521
| -32% | -$219K | ﹤0.01% | 1758 |
|
|
2024
Q4 | $670K | Buy |
48,087
+9,754
| +25% | +$107K | ﹤0.01% | 1104 |
|
|
2024
Q3 | $356K | Sell |
38,333
-60,828
| -61% | -$600K | ﹤0.01% | 1988 |
|
|
2024
Q2 | $922K | Buy |
99,161
+83,452
| +531% | +$755K | 0.01% | 1342 |
|
|
2024
Q1 | $156K | Sell |
15,709
-8,647
| -36% | -$64.5K | ﹤0.01% | 2166 |
|
|
2023
Q4 | $79K | Buy |
+24,356
| New | +$66.2K | ﹤0.01% | 2830 |
|
|
2023
Q3 | – | Sell |
-28,414
| Closed | -$271K | – | 3097 |
|
|
2023
Q2 | $271K | Buy |
28,414
+2,932
| +12% | +$32.5K | ﹤0.01% | 1663 |
|
|
2023
Q1 | $280K | Buy |
+25,482
| New | +$369K | ﹤0.01% | 2171 |
|
|
2022
Q4 | – | Sell |
-11,296
| Closed | -$216K | – | 3053 |
|
|
2022
Q3 | $216K | Sell |
11,296
-2,350
| -17% | -$53.2K | ﹤0.01% | 2258 |
|
|
2022
Q2 | $291K | Buy |
+13,646
| New | +$280K | ﹤0.01% | 2396 |
|
|
2022
Q1 | – | Sell |
-8,251
| Closed | -$171K | – | 2950 |
|
|
2021
Q4 | $171K | Sell |
8,251
-11,532
| -58% | -$230K | ﹤0.01% | 2746 |
|
|
2021
Q3 | $473K | Sell |
19,783
-5,065
| -20% | -$116K | ﹤0.01% | 2564 |
|
|
2021
Q2 | $678K | Buy |
24,848
+2,066
| +9% | +$58.2K | ﹤0.01% | 1790 |
|
|
2021
Q1 | $659K | Buy |
+22,782
| New | +$711K | ﹤0.01% | 1817 |
|
|
2020
Q3 | – | Sell |
-8,142
| Closed | -$246K | – | 2698 |
|
|
2020
Q2 | $246K | Buy |
8,142
+4,456
| +121% | +$129K | ﹤0.01% | 2686 |
|
|
2020
Q1 | $110K | Buy |
+3,686
| New | +$99K | ﹤0.01% | 2925 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
